Phase II study of carboplatin/nab-paclitaxel/atezolizumab combination therapy for advanced nonsquamous non–small cell lung cancer patients with impaired renal function: RESTART tri...

por Shiraishi, Yoshimasa, Kishimoto, Junji, Shimose, Takayuki, Toi, Yukihiro, Sugawara, Shunichi, Okamoto, Isamu
Publicado 2022

Forthcoming Phase II Study of Durvalumab (MEDI4736) Plus Chemotherapy for Small Cell Lung Cancer with Brain Metastases

por Shiraishi, Yoshimasa, Shimose, Takayuki, Tsuchiya-Kawano, Yuko, Ishii, Hidenobu, Daga, Haruko, Ito, Kentaro, Saruwatari, Koichi, Okamoto, Isamu
Publicado 2022

Phase II study of durvalumab (MEDI 4736) plus carboplatin and etoposide in elderly patients with extensive stage small cell lung cancer: Study protocol of turtle study (LOGIK 2003)

por Ishii, Hidenobu, Azuma, Koichi, Shimose, Takayuki, Yoshioka, Hiroshige, Kurata, Takayasu, Shingu, Naoki, Okamoto, Masaki, Kawashima, Yosuke, Okamoto, Isamu
Publicado 2022

Rationale and design of phase II clinical trial of dual inhibition with ramucirumab and erlotinib in EGFR exon 19 deletion-positive treatment-naïve non-small cell lung cancer with...

por Kawachi, Hayato, Yamada, Tadaaki, Yoshimura, Akihiro, Morimoto, Kenji, Iwasaku, Masahiro, Tokuda, Shinsaku, Kim, Young Hak, Shimose, Takayuki, Takayama, Koichi
Publicado 2023

Exploration of resistance mechanisms for epidermal growth factor receptor‐tyrosine kinase inhibitors based on plasma analysis by digital polymerase chain reaction and next‐generati...

por Iwama, Eiji, Sakai, Kazuko, Azuma, Koichi, Harada, Daijiro, Nosaki, Kaname, Hotta, Katsuyuki, Nishio, Makoto, Kurata, Takayasu, Fukuhara, Tatsuro, Akamatsu, Hiroaki, Goto, Koichi, Shimose, Takayuki, Kishimoto, Junji, Nakanishi, Yoichi, Nishio, Kazuto, Okamoto, Isamu
Publicado 2018

Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open‐Label, Randomized Control Study

por Nanishi, Etsuro, Nishio, Hisanori, Takada, Hidetoshi, Yamamura, Kenichiro, Fukazawa, Mitsuharu, Furuno, Kenji, Mizuno, Yumi, Saigo, Kenjiro, Kadoya, Ryo, Ohbuchi, Noriko, Onoe, Yasuhiro, Yamashita, Hironori, Nakayama, Hideki, Hara, Takuya, Ohno, Takuro, Takahashi, Yasuhiko, Hatae, Ken, Harada, Tatsuo, Shimose, Takayuki, Kishimoto, Junji, Ohga, Shouichi, Hara, Toshiro
Publicado 2017

A Phase II Trial on Osimertinib as a First-Line Treatment for EGFR Mutation-Positive Advanced NSCLC in Elderly Patients: The SPIRAL-0 Study

por Chihara, Yusuke, Takeda, Takayuki, Goto, Yasuhiro, Nakamura, Yoichi, Tsuchiya-Kawano, Yuko, Nakao, Akira, Onoi, Keisuke, Hibino, Makoto, Fukuda, Minoru, Honda, Ryoichi, Yamada, Takahiro, Taniguchi, Ryusuke, Sakamoto, Sinjiro, Date, Koji, Nagashima, Seiji, Tanzawa, Shigeru, Minato, Koichi, Nakatani, Koichi, Izumi, Miiru, Shimose, Takayuki, Kishimoto, Junji, Uchino, Junji, Takayama, Koichi
Publicado 2022